Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer

Field Value
Model ID12-040-01
Model NameRomond 2012
Pubmed ID22987084
First AuthorRomond
JournalJournal of Clinical Oncology
Year2012
TitleSeven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer
Primary Index ConditionCancer
Secondary Index ConditionNOS
OutcomeMACE
Model Sample SizeTo be updated
Cohort Sample SizeTo be updated
Number of EventsTo be updated
Follow-Up DurationTo be updated
AUROC0.72
Calibration Reported1
CovariatesTo be updated
Mesh TermsTo be updated
Number of Validations0

External Validations